Resurgent Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $212K | Buy |
523
+4
| +0.8% | +$1.62K | 0.12% | 177 |
|
2025
Q1 | $258K | Buy |
519
+6
| +1% | +$2.99K | 0.16% | 151 |
|
2024
Q4 | $267K | Sell |
513
-3
| -0.6% | -$1.56K | 0.16% | 147 |
|
2024
Q3 | $319K | Sell |
516
-4
| -0.8% | -$2.47K | 0.19% | 138 |
|
2024
Q2 | $288K | Buy |
520
+51
| +11% | +$28.2K | 0.18% | 144 |
|
2024
Q1 | $273K | Buy |
469
+8
| +2% | +$4.65K | 0.15% | 154 |
|
2023
Q4 | $245K | Buy |
461
+120
| +35% | +$63.7K | 0.15% | 148 |
|
2023
Q3 | $173K | Sell |
341
-66
| -16% | -$33.4K | 0.12% | 162 |
|
2023
Q2 | $212K | Buy |
407
+5
| +1% | +$2.61K | 0.14% | 135 |
|
2023
Q1 | $232K | Sell |
402
-172
| -30% | -$99.1K | 0.15% | 129 |
|
2022
Q4 | $316K | Sell |
574
-10
| -2% | -$5.51K | 0.17% | 134 |
|
2022
Q3 | $296K | Buy |
584
+28
| +5% | +$14.2K | 0.2% | 134 |
|
2022
Q2 | $302K | Buy |
+556
| New | +$302K | 0.19% | 129 |
|